Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.
Schlauch, K A, Khaiboullina, S F, De Meirleir, K L et al. · Translational psychiatry · 2016 · DOI
Quick Summary
Researchers compared the genes of people with ME/CFS to healthy people and found 442 genetic differences that may be linked to the condition. While most of these differences were in non-coding parts of the genome, some were in actual genes that produce proteins, including two that change how proteins work. Some genetic differences were found in genes related to the immune system's T-cells, which fight infection.
Why It Matters
This study is the first comprehensive genetic survey of ME/CFS, suggesting the condition has a heritable component. Identifying genes involved in immune function and pattern recognition may point toward biological mechanisms and potential therapeutic targets. Understanding genetic factors could eventually help with diagnosis and personalized treatment approaches.
Observed Findings
442 SNPs showed candidate-level association with ME/CFS (adjusted P<0.05)
Two missense mutations were identified in coding regions: one in a pattern recognition receptor and one in an uncharacterized coiled-coil protein
Five SNPs clustered in non-coding regions of T-cell receptor loci
Twelve SNPs total were in coding regions of genes
Majority of candidate SNPs were located in non-coding genomic regions
Inferred Conclusions
ME/CFS has a genetic predisposition component, with multiple genetic variants contributing to disease risk
Immune system genes, particularly T-cell receptor loci, may play a role in ME/CFS pathophysiology
Pattern recognition and immune signaling pathways are potential biological targets for understanding disease mechanisms
Genetic variants in coding regions affecting protein function warrant further investigation as contributors to ME/CFS etiology
Remaining Questions
Which of the 442 candidate SNPs are true disease-associated variants versus false positives?
How do the identified genetic variants interact with environmental factors to trigger or modulate ME/CFS?
What This Study Does Not Prove
This study does not prove that any single gene causes ME/CFS, as no variants reached genome-wide significance and the condition is multifactorial. Genetic association does not establish causation—these variants may contribute to risk but are not deterministic. The findings cannot explain all cases of ME/CFS or predict who will develop the condition.